Apellis Pharmaceuticals Inc (APLS) — Cash Flow Quality Index
Apellis Pharmaceuticals Inc (APLS) has a Cash Flow Quality Index of -3.27x as of March 2026. Operating cash flow of $-60.97 Million is below net income of $18.66 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore APLS operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Apellis Pharmaceuticals Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Apellis Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check APLS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Apellis Pharmaceuticals Inc (2025–2025)
Year-by-year earnings quality comparison for Apellis Pharmaceuticals Inc. For live market cap and the full company financial profile, see how much is Apellis Pharmaceuticals Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.02x | $45.33 Million | $22.39 Million | — |